FFCP PHASE2:Hg19::chr2:190448096..190448099,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p15@SLC40A1 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_15_at_SLC40A1_5end |
| Coexpression cluster: | C212_chronic_acute_Whole_Reticulocytes_leukemia_blood_CD34 |
| Association with transcript: | 28bp_to_ENST00000440626_5end |
| EntrezGene: | SLC40A1 |
| HGNC: | 10909 |
| UniProt: | Q4PNE6 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p15@SLC40A1 |
|---|
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| chronic myeloid leukemia | 9.91e-41 | 1 |
| myeloid leukemia | 4.39e-21 | 31 |
| leukemia | 6.34e-17 | 39 |
| hematologic cancer | 4.06e-13 | 51 |
| immune system cancer | 4.06e-13 | 51 |
Showing 1 to 5 of 5 entries
